secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001437749-25-038605
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences settles securities class action for $31.25M
------------------------------------------------------------

- Company to pay $31.25M into escrow in January 2026 to settle consolidated securities class action.
- Settlement covers claims from September 14, 2020 to October 12, 2023; releases all named defendants.
- Company had previously recorded a $31.25M loss contingency in Q2 2025 for this litigation.
- Settlement is not an admission of fault; formal stipulation to be filed for court approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774925038605/0001437749-25-038605-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774925038605/sava20251222_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-038605

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer